Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 456

1.

Chronic graft-versus-host disease after granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation: the role of donor T-cell dose and differentiation.

MacDonald KP, Rowe V, Filippich C, Johnson D, Morris ES, Clouston AD, Ferrara JL, Hill GR.

Biol Blood Marrow Transplant. 2004 Jun;10(6):373-85.

PMID:
15148491
[PubMed - indexed for MEDLINE]
2.

Donor pretreatment with progenipoietin-1 is superior to granulocyte colony-stimulating factor in preventing graft-versus-host disease after allogeneic stem cell transplantation.

MacDonald KP, Rowe V, Filippich C, Thomas R, Clouston AD, Welply JK, Hart DN, Ferrara JL, Hill GR.

Blood. 2003 Mar 1;101(5):2033-42. Epub 2002 Oct 17.

PMID:
12393418
[PubMed - indexed for MEDLINE]
Free Article
3.
5.

Donor treatment with pegylated G-CSF augments the generation of IL-10-producing regulatory T cells and promotes transplantation tolerance.

Morris ES, MacDonald KP, Rowe V, Johnson DH, Banovic T, Clouston AD, Hill GR.

Blood. 2004 May 1;103(9):3573-81. Epub 2004 Jan 15.

PMID:
14726406
[PubMed - indexed for MEDLINE]
Free Article
6.

Granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation maintains graft-versus-leukemia effects through a perforin-dependent pathway while preventing graft-versus-host disease.

Pan L, Teshima T, Hill GR, Bungard D, Brinson YS, Reddy VS, Cooke KR, Ferrara JL.

Blood. 1999 Jun 15;93(12):4071-8.

PMID:
10361103
[PubMed - indexed for MEDLINE]
Free Article
7.

Long-term engraftment, graft-vs.-host disease, and immunologic reconstitution after experimental transplantation of allogeneic peripheral blood cells from G-CSF-treated donors.

Pan L, Bressler S, Cooke KR, Krenger W, Karandikar M, Ferrara JL.

Biol Blood Marrow Transplant. 1996 Oct;2(3):126-33.

PMID:
9199755
[PubMed - indexed for MEDLINE]
8.

Stem cell mobilization with G-CSF induces type 17 differentiation and promotes scleroderma.

Hill GR, Olver SD, Kuns RD, Varelias A, Raffelt NC, Don AL, Markey KA, Wilson YA, Smyth MJ, Iwakura Y, Tocker J, Clouston AD, Macdonald KP.

Blood. 2010 Aug 5;116(5):819-28. doi: 10.1182/blood-2009-11-256495. Epub 2010 Apr 30.

PMID:
20435882
[PubMed - indexed for MEDLINE]
Free Article
9.

[A pilot study of G-CSF mobilized allogeneic bone marrow cells plus peripheral blood stem cells transplantation for malignant hematological diseases].

Chen Y, Huang X, Xu L, Liu D, Zhang Y, Ren H, Guo N, Lu D.

Zhonghua Yi Xue Za Zhi. 2002 Oct 10;82(19):1306-9. Chinese.

PMID:
12509932
[PubMed - indexed for MEDLINE]
10.

[Influence of G-CSF mobilization on functions of donor T lymphocyte subpopulation and acute graft-versus-host disease].

Liu QG, Yang DL, Huang Y, Jiang EL, Zhou SY, He Y, Wang ZD, Wang M, Zhou Z, Zai WJ, Feng SZ, Han MZ.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006 Feb;14(1):107-11. Chinese.

PMID:
16584603
[PubMed - indexed for MEDLINE]
11.
12.

Allogeneic stem cell transplantation with peripheral blood stem cells mobilized by pegylated G-CSF.

Hill GR, Morris ES, Fuery M, Hutchins C, Butler J, Grigg A, Roberts A, Bradstock K, Szer J, Kennedy G, Morton J, Durrant S.

Biol Blood Marrow Transplant. 2006 Jun;12(6):603-7.

PMID:
16737933
[PubMed - indexed for MEDLINE]
13.

TGF-beta in allogeneic stem cell transplantation: friend or foe?

Banovic T, MacDonald KP, Morris ES, Rowe V, Kuns R, Don A, Kelly J, Ledbetter S, Clouston AD, Hill GR.

Blood. 2005 Sep 15;106(6):2206-14. Epub 2005 Jun 7.

PMID:
15941908
[PubMed - indexed for MEDLINE]
Free Article
14.

Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.

Chen XH, Zhang C, Zhang X, Gao L, Gao L, Kong PY, Peng XG, Qi DG, Sun AH, Zeng DF, Liu H, Gong Y, Wang QY.

Biol Blood Marrow Transplant. 2009 Feb;15(2):266-73. doi: 10.1016/j.bbmt.2008.11.029. Erratum in: Biol Blood Marrow Transplant. 2009 Apr;15(4):521.

PMID:
19167687
[PubMed - indexed for MEDLINE]
15.

Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells.

Arpinati M, Green CL, Heimfeld S, Heuser JE, Anasetti C.

Blood. 2000 Apr 15;95(8):2484-90.

PMID:
10753825
[PubMed - indexed for MEDLINE]
Free Article
16.

Evidence that donor intrinsic response to G-CSF is the best predictor of acute graft-vs-host disease following allogeneic peripheral blood stem cell transplantation.

Dhédin N, Chamakhi I, Perreault C, Roy DC, Sauvageau G, Ducruet T, Busque L, Fish D, Bélanger R, Roy J.

Exp Hematol. 2006 Jan;34(1):107-14.

PMID:
16413397
[PubMed - indexed for MEDLINE]
17.

Donor cell reaction to OKT3 as predictor of chronic graft-vs-host disease in hematopoietic stem cell recipients.

Lindemann M, Ottinger HD, Elmaagacli AH, Trenschel R, Rebmann V, Beelen DW, Grosse-Wilde H.

Exp Hematol. 2006 Dec;34(12):1753-8.

PMID:
17157173
[PubMed - indexed for MEDLINE]
18.

Treatment of relapse after allogeneic bone marrow transplantation with unmanipulated G-CSF-mobilized peripheral blood stem cell preparation.

Siegert W, Beyer J, Kingreen D, Blasczyk R, Baurmann H, Schwella N, Schleicher J, Kirsch A, Huhn D.

Bone Marrow Transplant. 1998 Sep;22(6):579-83.

PMID:
9758347
[PubMed - indexed for MEDLINE]
Free Article
19.

Immunotherapy of murine leukemia following non-myeloablative conditioning with naïve or G-CSF mobilized blood or bone marrow stem cells.

Weiss L, Or R, Slavin S, Naparstek E, Reich S, Abdul-Hai A.

Cancer Immunol Immunother. 2004 Apr;53(4):358-62. Epub 2003 Nov 5.

PMID:
14605765
[PubMed - indexed for MEDLINE]
20.

The role of accessory cells in allogeneic peripheral blood stem cell transplantation.

Tanaka J, Imamura M, Kasai M, Asaka M, Torok-Storb B.

Int J Hematol. 1999 Feb;69(2):70-4. Review.

PMID:
10071453
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk